3T Biosciences vs Achilles Therapeutics plc
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for broad patient populations
26 employees · est. 2017 · South San Francisco, United...
Achilles Therapeutics plc
Personalised T cell therapies targeting clonal neoantigens
39 employees · est. 2016 · United Kingdom
Achilles Therapeutics plc is the older company (2017 vs 2016).
Side-by-Side Comparison
| Metric | 3T Biosciences | Achilles Therapeutics plc |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2016 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | United Kingdom |
| Employees | ||
| Employees | 26 | 39 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Grant |
| Total Funding | ||
| Total Funding | $52.00M | $170.70M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | Development of transformative therapies, Treatment for solid tumors, Innovative immunotherapy solutions | Biotechnology Research and Development, Therapeutic Solutions, Liquidation Management, Financial Advisory |
| Target Customers | ||
| Target Customers | Patients with solid tumors, Broad patient populations, Healthcare providers | Investors, Shareholders, Creditors, Biotechnology Researchers, Healthcare Industry Stakeholders |
| Taxonomy | ||
| Taxonomy | ImmunotherapyNext-generation TherapiesTransformative TherapiesSolid TumorsImmune-mediated DiseasesBroad Patient Populations +8 | Personalized MedicineT Cell TherapiesTruncal NeoantigensCancer ImmunotherapyBioinformaticsOncology +8 |
| Website | ||
| Website | 3tbiosciences.com | achillestx.com |
About 3T Biosciences
3T Biosciences, founded in 2017 and headquartered in the United States, is an emerging player in the Biopharma and Biotechnology sectors. The company is dedicated to revolutionizing immunotherapy by developing next-generation therapies aimed at treating solid tumors and other immune-mediated disease...
About Achilles Therapeutics plc
Achilles Therapeutics plc, founded in 2016 and headquartered in the United Kingdom, operates at the intersection of Biotechnology, Health Care, and Health and Wellness. The company is pioneering next-generation, personalized therapies that leverage the immune system to eradicate cancer cells. With...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches 3T Biosciences and Achilles Therapeutics plc for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when 3T Biosciences or Achilles Therapeutics plc moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare 3T Biosciences with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at 3T Biosciences on 4 Jun 2026, and Achilles Therapeutics plc on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
